Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001010412-11-000602
Filing Date
2011-11-09
Accepted
2011-11-08 19:20:17
Documents
10
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED SEPTEMBER 30, 2011 skin_11q3final.htm 10-Q 122043
2 302 CERTIFICATION OF CEO ex311.htm EX-31 5896
3 302 CERTIFICATION OF CFO ex312.htm EX-31 6000
4 SECTION 1350 CERTIFICATION ex32.htm EX-32 2654
  Complete submission text file 0001010412-11-000602.txt   624341

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT skin-20110930.xml EX-101.INS 29344
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT skin-20110930_pre.xml EX-101.PRE 43608
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT skin-20110930_lab.xml EX-101.LAB 58406
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT skin-20110930_def.xml EX-101.DEF 34891
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT skin-20110930_cal.xml EX-101.CAL 16863
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT skin-20110930.xsd EX-101.SCH 6334
Mailing Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106
Business Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106 8013232395
SKINOVATION PHARMACEUTICAL INC (Filer) CIK: 0001118072 (see all company filings)

EIN.: 870458170 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30991 | Film No.: 111189138
SIC: 6770 Blank Checks